CTOs on the Move

MPI Research

www.mpiresearch.com

 
MPI Research, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. MPI Research, Inc. is based in Mattawan, MI. You can find more information on MPI Research, Inc. at www.mpiresearch.com
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Planned Parenthood

Planned Parenthood Federation of America is a nonprofit organization that provides sexual health care in the United States and globally. They are a trusted health care provider, an informed educator, a passionate advocate, and a global partner helping ...

AcelRx

AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company`s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and ZALVISO®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. In clinical studies, DSUVIA demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and vomiting. A New Drug Application (NDA) was filed with the FDA in December 2016. ZALVISO is designed to deliver sublingual tablets containing 15 mcg sufentanil via a novel hand-held, pre-programmed, patient-controlled analgesia system. Three Phase 3 clinical trials have been completed in patients who had undergone major abdominal or orthopedic surgeries. A fourth study (IAP312) is underway to further evaluate the overall performance of the ZALVISO System in post-surgical patients. ZALVISO is currently approved by the European Commission for the management of acute moderate-to-severe post-operative pain in adult patients in a hospital setting, and is marketed by Grünenthal Group, AcelRx`s licensee in Europe and Australia. In the United States and other geographies, ZALVISO remains an investigational product.

Recovree

We help people find and maintain recovery from substance misuse through peer relationships. Recovree provides services to support the health and wellness of employees including on-demand access to recovery coaches with lived-experience, comprehensive chemical health assessments, and incident response planning. Employees struggling with drug and alcohol addiction can have a significant impact on a company`s productivity, safety and culture. Our services help employers retain top talent, improve the health and wellness of their teams and provide better access to resources for people who need help now. Check out our Recovery Friendly Workplace Toolkit, where we introduce you to the disease of substance use disorder, its impact in the workplace, and how to create and support a recovery friendly workplace. Our goal is to provide you with practical tools and information that you can implement within your company. We want to help you improve the lives of your employees and save money.

IARP Headquarters

IARP Headquarters is a Santa Cruz, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

XLTek

XLTek is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.